22.728 articles found

VACCINE AND METHOD FOR TREATMENT OF NEURODEGENERATIVE DISEASES

EISENBACH-SCHWARTZ MICHAL, YOLES ESTER, BUTOVSKY OLEG, KIPNIS JONATHAN.

· 2011-04-29

Therapeutic effects of hydrogen in animal models of Parkinson's disease.

Fujita K, Nakabeppu Y, Noda M.

Parkinsons Dis · 2011-04-26

DOI: 10.4061/2011/307875PMID: 21687749

Significant effects of 4-aminopyridine and tetraethylammonium in the treatment of 6-hydroxydopamine-induced Parkinson's disease.

Haghdoost-Yazdi H, Faraji A, Fraidouni N, Movahedi M, Hadibeygi E, Vaezi F.

Behav Brain Res · 2011-04-21

DOI: 10.1016/j.bbr.2011.04.021PMID: 21540059

Yeast Screens for Treatment of Human Disease

LINDQUIST SUSAN, KROBITSCH SYLVIA, OUTEIRO TIAGO FLEMING.

· 2011-04-20

Balance control improves following replacement of paroxetine with venlafaxine and levodopa in a case of microvascular dementia.

McDonald J, Corbeil P, Pourcher E.

Am J Geriatr Pharmacother · 2011-04-19

DOI: 10.1016/j.amjopharm.2011.03.002PMID: 21507731

Brain 5-HT(2A) receptors in MPTP monkeys and levodopa-induced dyskinesias.

Riahi G, Morissette M, Parent M, Di Paolo T.

Eur J Neurosci · 2011-04-19

DOI: 10.1111/j.1460-9568.2011.07675.xPMID: 21501255

Rhabdomyolysis induced by severe levodopa induced dyskinesia in a patient with Parkinson's disease.

Lyoo CH, Lee MS.

J Neurol · 2011-04-16

DOI: 10.1007/s00415-011-6041-xPMID: 21499722

TREATMENT WITH A PHARMACEUTICAL COMPOSITION COMPRISING MANF2 NUCLEIC ACID

SAARMA MART, LAUREN JUHA, LINDHOLM PAEIVI, TIMMUSK TONIS, TUOMINEN RAIMO.

· 2011-04-15

Should treatment for Parkinson's disease start immediately on diagnosis or delayed until functional disability develops?

Clarke CE, Patel S, Ives N, Rick C, Wheatley K, Gray R.

Mov Disord · 2011-04-14

DOI: 10.1002/mds.23519PMID: 21495068

PROCESS FOR TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS, RHEUMATOID ARTHRITIS, TREMORS/PARKINSON'S DISEASE, MULTIPLE SCLEROSIS, NON-VIRAL BASED CANCERS, ALZHEIMER'S DISEASE, MUSCULAR DYSTROPHY, ATTENTION DEFICIT DISORDER, ATTENTION DEFICIT HYPERACTIVI

NELSON GEORGE.

· 2011-04-13

Tetrabenazine for the treatment of tardive dyskinesia.

Leung JG, Breden EL.

Ann Pharmacother · 2011-04-12

DOI: 10.1345/aph.1p312PMID: 21487088

Parkinson disease: Gene therapy for Parkinson disease shows promise in phase II trial.

Kingwell K.

Nat Rev Neurol · 2011-04-12

DOI: 10.1038/nrneurol.2011.48PMID: 21487423